Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Nunn E. et al Molecular Metabolism. 1/11/2024.

Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism

Nunn E. et al

Molecular Metabolism

1/11/2024